-
New data boosts Roche lung cancer combo
pharmaphorum
March 30, 2018
Roche is hoping new data will help its cancer immunotherapy Tecentriq gain more traction, and prolong the shelf-life of its older cancer medicine Avastin.
-
Five Deaths in Genentech's Hemlibra Patients
biospace
March 29, 2018
The American Hemophilia Federation and the National Hemophilia Foundation announced that they have contacted Genentech, a Roche company
-
Roche says Tecentriq, Avastin, chemotherapy combination prolongs survival in lung cancer study
firstwordpharma
March 27, 2018
Roche announced Monday that the Phase III IMpower150 study met its co-primary endpoint of overall survival (OS)
-
Roche’s Tecentriq hits mark in squamous NSCLC – how loud are Merck & Co.’s footsteps?
firstwordpharma
March 23, 2018
Roche Tecentriq (atezolizumab) plus chemotherapy for prolonged progression-free survival (PFS) as a first-line treatment in the stage III IMpower 131 trial for squamous cell carcinoma non-small cell lung cancer (NSCLC)
-
Roche’s Tecentriq halts disease in squamous lung cancer
pharmaphorum
March 21, 2018
Roche’s cancer immunotherapy Tecentriq has produced strong results which could give it the lead in a key lung cancer indication.
-
Precision BioLogic Presents New Approach to Standardize and Improve Inhibitor Testing for People wit
biospace
March 14, 2018
Precision BioLogic cooperates with Roche and Genentech under the Roche Group
-
BioMed X, Roche Enter Immunology Research Pact
contractpharma
March 13, 2018
BioMed X has entered a new research collaboration with F. Hoffmann-La Roche in the field of immunology
-
Pao to head drugs research at Roche
biospectrumasia
March 09, 2018
Pao, now head of the oncology discovery and translational area for pRED, assumes his new role on April 2.
-
Roche's John Reed Is Stepping Down
biospace
March 09, 2018
John Reed, who for five years has led Roche’s Pharma Research and Early Development (pRED) research group, is stepping down for personal reasons and leaving Switzerland to return to the United States.
-
Roche and Takeda use Organs-On-Chip technology for R&D
biospectrumasia
March 05, 2018
Roche and Takeda will be using organ-chip technology in their R&D by partnering with Emulate, the biotech startup behind organs-on-a-chip